ArticleCurrent medical science2023

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Emergency Complex Higher-risk and Indicated Patients.

Zhi-Li Jin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.